[go: up one dir, main page]

AR074190A1 - ACIDOSIS CONTROLLING AGENT FOR A RUMINANT. COMPOSITION. METHOD. I THINK. USE. - Google Patents

ACIDOSIS CONTROLLING AGENT FOR A RUMINANT. COMPOSITION. METHOD. I THINK. USE.

Info

Publication number
AR074190A1
AR074190A1 ARP090104255A ARP090104255A AR074190A1 AR 074190 A1 AR074190 A1 AR 074190A1 AR P090104255 A ARP090104255 A AR P090104255A AR P090104255 A ARP090104255 A AR P090104255A AR 074190 A1 AR074190 A1 AR 074190A1
Authority
AR
Argentina
Prior art keywords
acidosis
composition
controlling agent
ruminant
think
Prior art date
Application number
ARP090104255A
Other languages
Spanish (es)
Inventor
Kyo Nagashima
Masami Mochizuki
Chie Suzuki
Original Assignee
Idemitsu Kosan Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idemitsu Kosan Co filed Critical Idemitsu Kosan Co
Publication of AR074190A1 publication Critical patent/AR074190A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Feed For Specific Animals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Agente controlador de la acidosis, que comprende líquido de pericarpio de castana de caju y/o ácido anacárdico. Reivindicacion 4: Una composicion para un pienso para controlar la acidosis, caracterizada porque comprende el agente controlador de la acidosis de acuerdo con la reivindicacion 1. Reivindicacion 5: Un pienso para controlar la acidosis, caracterizado porque comprende la composicion para un pienso para controlar la acidosis de acuerdo con la reivindicacion 4.Acidosis controlling agent, comprising cashew nut pericarp fluid and / or anacardic acid. Claim 4: A composition for a feed for controlling acidosis, characterized in that it comprises the acidosis controlling agent according to claim 1. Claim 5: A feed for controlling acidosis, characterized in that it comprises the composition for a feed for controlling acidosis according to claim 4.

ARP090104255A 2008-11-04 2009-11-04 ACIDOSIS CONTROLLING AGENT FOR A RUMINANT. COMPOSITION. METHOD. I THINK. USE. AR074190A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008283066 2008-11-04

Publications (1)

Publication Number Publication Date
AR074190A1 true AR074190A1 (en) 2010-12-29

Family

ID=42152893

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090104255A AR074190A1 (en) 2008-11-04 2009-11-04 ACIDOSIS CONTROLLING AGENT FOR A RUMINANT. COMPOSITION. METHOD. I THINK. USE.

Country Status (3)

Country Link
JP (1) JPWO2010053085A1 (en)
AR (1) AR074190A1 (en)
WO (1) WO2010053085A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3466437T3 (en) 2011-01-07 2022-01-31 Idemitsu Kosan Co Agent for the prevention or therapy of perinatal diseases for ruminants
AU2015252032B2 (en) * 2011-01-07 2016-07-07 Sds Biotech K.K. Agent for improving milk yield and/or milk quality of ruminants, preventive or therapeutic agent for perinatal disease, and agent for improving reproductive efficiency
AU2016204291B2 (en) * 2011-01-07 2016-12-22 Sds Biotech K.K. Agent for improving milk yield and/or milk quality of ruminants, preventive or therapeutic agent for perinatal disease, and agent for improving reproductive efficiency
AR120346A1 (en) 2019-10-31 2022-02-09 Idemitsu Kosan Co AGENT TO SUPPRESS INSULIN RESISTANCE IN RUMINANTS
JP7519661B2 (en) 2019-12-03 2024-07-22 株式会社エス・ディー・エス バイオテック Inflammatory inhibitor for intestinal cells
BR112023024751A2 (en) 2021-05-28 2024-02-15 Sds Biotech Corp ANTI-INFLAMMATORY AGENT FOR DOMESTIC ANIMAL INTESTINAL CELLS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08231410A (en) * 1995-02-23 1996-09-10 Takasago Internatl Corp Coccidiosis-reducing agent and feed containing the same
US6258046B1 (en) * 1995-07-06 2001-07-10 Institute Of Critical Care Medicine Method and device for assessing perfusion failure in a patient by measurement of blood flow
JP4680339B2 (en) * 1999-11-26 2011-05-11 日清丸紅飼料株式会社 Feed for prevention and / or treatment of coccidiosis
JP2003238400A (en) * 2002-02-12 2003-08-27 Nippon Zenyaku Kogyo Kk Anticoccidial composition and fodder containing the same
EP2165609B1 (en) * 2007-06-08 2013-12-04 Idemitsu Kosan Co., Ltd. Rumen fermentation improving agent

Also Published As

Publication number Publication date
JPWO2010053085A1 (en) 2012-04-05
WO2010053085A1 (en) 2010-05-14

Similar Documents

Publication Publication Date Title
BRPI0812886A2 (en) AGENT FOR THE CONTROL OF SWELL FOR A RUMINANT, COMPOSITION AND FEED FOR CONTROLING A SWELL, METHOD FOR CONTROLING THE SWELL OF A RUMINANT, AND USE OF CASHEW NUTS.
CL2008003653A1 (en) Use of a glucopyranosyl-derived sglt inhibitor and a selected dppiv inhibitor to treat diabetes; and pharmaceutical composition.
BR112013018352A2 (en) topical minocycline composition and method
CL2008000510A1 (en) FARMACO-LIGANDOS CONJUGATED COMPOUNDS, THAT JOIN POWERFUL CITOTOXINS; PHARMACEUTICAL COMPOSITION; AND USE TO DELAY OR STOP THE GROWTH OF A TUMOR IN A MAMMER.
CL2012000348A1 (en) Method for treating or reducing the severity of osteoporosis or osteopenia in a patient comprising administering the compound n- [2,4-bis (1,1-dimethylethyl) -5-hydroxyphenyl] -1,4-dihydro-4-oxoquinoline -3-carboxamide or a salt thereof; pharmaceutical composition.
AR074190A1 (en) ACIDOSIS CONTROLLING AGENT FOR A RUMINANT. COMPOSITION. METHOD. I THINK. USE.
BRPI0717845A2 (en) Use of compounds, pharmaceutical compositions and methods for the treatment and / or prophylaxis of diseases that can be treated with HDL-cholesterol elevating agents and compounds.
ECSP109852A (en) USE OF HOMO AND COPOLYMERS FOR THE STABILIZATION OF FORMULATIONS OF ACTIVE PRINCIPLES
CL2008001656A1 (en) Anti-c3b antibody; pharmaceutical composition comprising it, and its use to prevent or treat a complement-associated disorder; kit containing it.
CL2011001811A1 (en) A method of treating a patient who has suffered an acute myocardial infarction that comprises the use of an antifibrotic agent.
CL2012000392A1 (en) Use of an afucosylated anti-cd20 antibody with a fucose amount of 60% or less to treat cancer in combination with fludarabine.
CL2012000958A1 (en) Non-combustion heat consumable product comprising an encapsulated aerosol generating agent; use of an aerosol generating agent encapsulated in said consumable product; and method of controlling the release of an aerosol generating agent.
CL2008000058A1 (en) FORMULATION THAT INCLUDES AN ANTI-IL13 ANTIBODY, A CRIPROTECTOR, AND A DAMPING SOLUTION; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; METHOD TO TREAT AN IL13-RELATED DISORDER; AND PHARMACEUTICAL FORMS THAT UNDERSTAND IT.
CL2010000516A1 (en) Solventless fungicidal composition comprising water insoluble strobirullin dispersed throughout the carrier material in nano-dispersed form having a peak diameter of the nano-dispersed form of less than 1000 nm; process for preparing said composition; use of said composition to treat an infestation (sun divisional. 2030-07).
CL2011000157A1 (en) Pitch emulsion, comprising water dispersed pitch, and an emulsifying agent based on fatty acid, rosin acid; method to prepare the emulsion; and method to reduce fugitive dust.
CR20150216A (en) COMPOSITIONS AND METHODS TO TREAT PROTEINOPATHIES
CL2009000803A1 (en) Use of a pegylated variant of igf-1 to treat, prevent a neuromuscular disorder; method for the treatment, prevention and / or delay of a neuromuscular disorder; composition comprising the modified igf-1 variant
CL2008002381A1 (en) Immunostimulatory oligonucleotide; pharmaceutical composition comprising it; and its use to treat a disorder or condition in a subject, including cancer.
BRPI0921249A2 (en) use of extracellular matrix in the preparation of a composition, use of extracellular matrix and chemotherapeutic agent in the preparation of a composition, and compositions for treating cancer.
CR11418A (en) TRANS-CLOMPHENE FOR METABOLIC SYNDROME
CL2011000214A1 (en) Pharmaceutical composition comprising micronized progesterone and type II safflower oil; and use for the treatment of a condition related to insufficient progesterone secretion.
CL2007000355A1 (en) A combination comprising a cyclin-dependent kinase inhibitor, an antibody that inhibits a growth factor and an antifungal agent; pharmaceutical composition that includes it; and its use to treat a proliferative disorder.
MX340388B (en) CLEANING DEVICE AND CLEANING BRUSH FOR AN ATOMIZER AND CORRESPONDING CLEANING METHOD.
AR070850A1 (en) DEVICE FOR IMPROVING A FLYING METHOD
NI201500118A (en) SUBSTITUTE IMIDAZOPYRIDAZINES

Legal Events

Date Code Title Description
FB Suspension of granting procedure